Chlordiazepoxide Hydrochloride and Clidinium Bromide (Marlex Pharmaceuticals Inc)
Welcome to the PulseAid listing for the Chlordiazepoxide Hydrochloride and Clidinium Bromide drug offered from Marlex Pharmaceuticals Inc. This Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Marlex Pharmaceuticals Inc |
NON-PROPRIETARY NAME: | Chlordiazepoxide Hydrochloride and Clidinium Bromide |
SUBSTANCE NAME: | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2016-07-01 |
END MARKETING DATE: | 0000-00-00 |
Chlordiazepoxide Hydrochloride and Clidinium Bromide HUMAN PRESCRIPTION DRUG Details:
Item Description | Chlordiazepoxide Hydrochloride and Clidinium Bromide from Marlex Pharmaceuticals Inc |
LABELER NAME: | Marlex Pharmaceuticals Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; 2.5(mg/1; mg/1) |
START MARKETING DATE: | 2016-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10135-622_f8f6572f-2f7c-4dee-a93e-da3c493e16f7 |
PRODUCT NDC: | 10135-622 |
APPLICATION NUMBER: | |
Other CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE Pharmaceutical Manufacturers / Labelers: